A commentary on Read, J., Kirsch, I., & McGrath, L. (2020). Electroconvulsive therapy for depression: A review of the quality of ECT versus sham ECT trials and meta-analyses. Ethical Human Psychology and Psychiatry, 21, 64-103. Richard P. Bentall, Professor of Clinical Psychology, University of Sheffield In a discipline to which controversy is no stranger, there are […]
The Council for Evidence-based Psychiatry, secretariat of the APPG for Prescribed Drug Dependence, wanted to provide a short update on the recent activities of the APPG. Following the publication of the PHE Prescribed Medicines Review in September last year, the APPG worked hard to secure a commitment from the Government for some of its key recommendations, […]
NICE depression guideline: cautious optimism? Susan McPherson, University of Essex This commentary is a revised and updated version of a Rapid Response letter to the BMJ in September 2019 posted prior to NICE’s decision letter of December 2019: https://www.bmj.com/content/365/bmj.l2356/rr-0 In a joint stakeholder position statement concerning the NICE 2018 draft depression guideline, six methodological issues were […]
The Disturbing Case of the Street Drug Ketamine The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression. In March this year, the USA’s Food and Drug Administration […]
The BBC is producing a documentary about the long-term side effects and withdrawal effects of antidepressant medication. They are looking to speak to individuals who have decided to come off their medication and would be open to allowing us to follow their journey throughout this process, alongside the reporter of the film who will be […]
CEP today welcomes the publication of a report by Public Health England which recognises for the first time the scale of prescribing of drugs that can cause dependence and withdrawal. The report shows that one in four adults in England has been prescribed a benzodiazepine, z-drug, gabapentinoid, opioid or antidepressant in the past twelve months, with up to […]
In our recent study published in the journal Psychotherapy and Psychosomatics, we showed that adults who start antidepressants for depression are 2.5 times more likely to attempt suicide when compared to those starting placebo. This equates to 1 in every 200 people attempting suicide as a direct effect of taking the antidepressant. This number is […]
This is the question raised at least every 2 months in our NHS psychosis team. Most of us will go without a second thought (I have to admit, I usually do. There are free M&S sandwiches, fruit, biscuits and pastries; “That’s all the moral compass I need”, I like to joke). We have the usual […]
Today the Council for Evidence-Based Psychiatry calls for the implementation of a UK Sunshine Act to make transparent the financial relationships between doctors and pharmaceutical companies & the makers of medical devices. It would be similar to the The Physician Payments Sunshine Act in the United States which was implemented by the Obama administration August 2013, and […]
Adults who start treatment with antidepressants for depression are 2.5 times more likely to attempt suicide when compared to placebo, according to new research published today in the journal Psychotherapy and Psychosomatics. The study found that approximately 1 in every 200 people who start treatment will attempt suicide due to the pharmacologic effects of the […]
